NASDAQ:AEMD Aethlon Medical - AEMD Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.68 -0.02 (-3.56%) (As of 02/2/2023 09:46 AM ET) Add Compare Share Share Today's Range$0.67▼$0.7050-Day Range$0.25▼$0.7052-Week Range$0.23▼$2.46Volume121,144 shsAverage Volume2.59 million shsMarket Capitalization$11.23 millionP/E RatioN/ADividend YieldN/APrice Target$4.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Aethlon Medical MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside471.5% Upside$4.00 Price TargetShort InterestHealthy1.26% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.36Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.80 out of 5 starsMedical Sector783rd out of 1,030 stocksSurgical & Medical Instruments Industry79th out of 105 stocks 3.0 Analyst's Opinion Consensus RatingAethlon Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.00, Aethlon Medical has a forecasted upside of 471.5% from its current price of $0.70.Amount of Analyst CoverageAethlon Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.26% of the outstanding shares of Aethlon Medical have been sold short.Short Interest Ratio / Days to CoverAethlon Medical has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aethlon Medical has recently increased by 97.09%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAethlon Medical does not currently pay a dividend.Dividend GrowthAethlon Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AEMD. Previous Next 3.0 News and Social Media Coverage News SentimentAethlon Medical has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Aethlon Medical this week, compared to 0 articles on an average week.Search Interest2 people have searched for AEMD on MarketBeat in the last 30 days. MarketBeat Follows3 people have added Aethlon Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aethlon Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.20% of the stock of Aethlon Medical is held by insiders.Percentage Held by InstitutionsOnly 11.86% of the stock of Aethlon Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Aethlon Medical is -0.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aethlon Medical is -0.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAethlon Medical has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Aethlon Medical (NASDAQ:AEMD) StockAethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.Read More Receive AEMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AEMD Stock News HeadlinesJanuary 31, 2023 | finance.yahoo.comAethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023January 30, 2023 | msn.comAethlon stock soars ~40% on pact for Hemopurifier clinical program in cancerFebruary 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 30, 2023 | marketwatch.comAethlon Medical Shares Soar 66% on NAMSA Clinical Trial ContractJanuary 30, 2023 | finance.yahoo.comAethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in CancerJanuary 30, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD)January 29, 2023 | americanbankingnews.comAethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 97.1% in JanuaryJanuary 29, 2023 | americanbankingnews.comAnalyzing Aethlon Medical (NASDAQ:AEMD) & Artivion (NYSE:AORT)February 2, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! November 16, 2022 | finance.yahoo.comAEMD: Hemopurifier Hemopurifier To Be Studied in a Variety of Solid TumorsNovember 15, 2022 | seekingalpha.comAethlon Medical, Inc. (AEMD) Q2 2022 Earnings Call TranscriptNovember 12, 2022 | msn.comPreview: Aethlon Medical's EarningsNovember 2, 2022 | finance.yahoo.comAethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022October 18, 2022 | seekingalpha.comAEMD Aethlon Medical, Inc.September 17, 2022 | finance.yahoo.comAethlon Medical, Inc. (AEMD)September 6, 2022 | finance.yahoo.comAethlon Medical to Present at Two Investor Conferences in SeptemberAugust 17, 2022 | finance.yahoo.comAEMD: Positive Results in a Range of Conditions, Including COVID-19 & Monkey PoxAugust 15, 2022 | finance.yahoo.comAethlon Medical, Inc. (NASDAQ:AEMD) Is About To Turn The CornerAugust 10, 2022 | seekingalpha.comAethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q1 2023 Results - Earnings Call TranscriptAugust 10, 2022 | finance.yahoo.comAethlon Medical To Start Lab Studies For Hemopurifier For MonkeypoxAugust 3, 2022 | finance.yahoo.comAethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022July 28, 2022 | finance.yahoo.comAethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 VariantsJuly 11, 2022 | nasdaq.comFDA Approves Aethlon Medical's Protocol Amendment For COVID-19 TrialJune 29, 2022 | seekingalpha.comAethlon Medical, Inc.'s (AEMD) CEO Chuck Fisher on Q4 2022 Results - Earnings Call TranscriptJune 29, 2022 | finance.yahoo.comAEMD: Positive Results in a Range of Conditions, Including COVID-19 & MonkeypoxJune 28, 2022 | seekingalpha.comAethlon Medical Q4 2022 Earnings PreviewJune 27, 2022 | benzinga.comEarnings Outlook For Aethlon MedicalSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AEMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AEMD Company Calendar Last Earnings11/14/2022Today2/02/2023Next Earnings (Estimated)2/13/2023Fiscal Year End3/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AEMD CUSIPN/A CIK773910 Webwww.aethlonmedical.com Phone(858) 459-7800FaxN/AEmployees10Year FoundedN/APrice Target and Rating Average Stock Price Forecast$4.00 High Stock Price Forecast$4.00 Low Stock Price Forecast$4.00 Forecasted Upside/Downside+492.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.78) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,420,000.00 Net MarginsN/A Pretax Margin-43,423.33% Return on Equity-72.02% Return on Assets-63.91% Debt Debt-to-Equity RatioN/A Current Ratio9.76 Quick Ratio9.76 Sales & Book Value Annual Sales$290,000.00 Price / Sales38.73 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / Book0.61Miscellaneous Outstanding Shares16,640,000Free Float16,106,000Market Cap$11.23 million OptionableNot Optionable Beta1.20 Key ExecutivesCharles J. FisherChief Executive Officer & DirectorJames B. FrakesChief Financial Officer, Secretary & Senior VPAnnette MarleauResearch DirectorSteven P. LaRosaChief Medical & Scientific OfficerGuy F. CiprianiDirector, Chief Business Officer & Senior VPKey CompetitorsMinerva SurgicalNASDAQ:UTRSGBSNYSE:GBST2 BiosystemsNASDAQ:TTOOInspira Technologies Oxy B.H.N.NASDAQ:IINNAvingerNASDAQ:AVGRView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 558,596 shares on 11/15/2022Ownership: 6.330%Citadel Advisors LLCBought 123,952 shares on 11/15/2022Ownership: 0.745%Two Sigma Investments LPBought 55,789 shares on 11/15/2022Ownership: 0.335%Buckingham Strategic PartnersBought 50,000 shares on 11/15/2022Ownership: 0.300%Renaissance Technologies LLCBought 62,336 shares on 11/14/2022Ownership: 0.375%View All Institutional Transactions AEMD Stock - Frequently Asked Questions Should I buy or sell Aethlon Medical stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AEMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AEMD, but not buy additional shares or sell existing shares. View AEMD analyst ratings or view top-rated stocks. What is Aethlon Medical's stock price forecast for 2023? 1 equities research analysts have issued twelve-month price objectives for Aethlon Medical's shares. Their AEMD share price forecasts range from $4.00 to $4.00. On average, they predict the company's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 471.5% from the stock's current price. View analysts price targets for AEMD or view top-rated stocks among Wall Street analysts. How have AEMD shares performed in 2023? Aethlon Medical's stock was trading at $0.2754 at the beginning of the year. Since then, AEMD stock has increased by 154.1% and is now trading at $0.6999. View the best growth stocks for 2023 here. Are investors shorting Aethlon Medical? Aethlon Medical saw a increase in short interest in January. As of January 15th, there was short interest totaling 209,900 shares, an increase of 97.1% from the December 31st total of 106,500 shares. Based on an average daily volume of 249,200 shares, the short-interest ratio is presently 0.8 days. View Aethlon Medical's Short Interest. When is Aethlon Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 13th 2023. View our AEMD earnings forecast. How were Aethlon Medical's earnings last quarter? Aethlon Medical, Inc. (NASDAQ:AEMD) released its quarterly earnings results on Monday, November, 14th. The medical equipment provider reported ($0.18) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.05. What other stocks do shareholders of Aethlon Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), Organigram (OGI), AT&T (T) and Aurora Cannabis (ACB). What is Aethlon Medical's stock symbol? Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD." Who are Aethlon Medical's major shareholders? Aethlon Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). View institutional ownership trends. How do I buy shares of Aethlon Medical? Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Aethlon Medical's stock price today? One share of AEMD stock can currently be purchased for approximately $0.70. How much money does Aethlon Medical make? Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $11.65 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis. How can I contact Aethlon Medical? Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for the company is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com. This page (NASDAQ:AEMD) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.